共 50 条
- [45] Long-acting muscarinic antagonist (LAMA) plus long-acting beta-agonist (LABA) versus LABA plus inhaled corticosteroid (ICS) for stable chronic obstructive pulmonary disease COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2023, (06):
- [46] Evaluating Safety and Adverse Events Associated with Long-Acting β-Agonist in Combination Asthma Therapy Versus Inhaled Corticosteroid Alone JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2017, 5 (04): : 1158 - 1161